HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

SUTL Enterprise Just Bought This Iconic Singapore Marina In FY2025

https://open.spotify.com/episode/7I5kOv9opzN4Mpb434LBKU?si=8eec96911e7a4de3 Charting a New Course: 4 Key Takeaways from SUTL Enterprise’s Bold FY2025 Growth Strategy Standing...
SGX-LISTED COMPANIES

Seatrium FY2025 Profits Double via Series Build Strategy

https://open.spotify.com/episode/4WSi7kfwIf0k3vqXAcI9vf?si=c5d5d5af831745db The $11.5 Billion Turnaround: 5 Surprising Takeaways from Seatrium’s Record-Breaking 2025 Industrial mega-mergers are notoriously...
SGX-LISTED COMPANIES

Megachem Bets On A High-Stake Specialty Chemical Rebuild In FY2025

https://open.spotify.com/episode/4RUoJWaAKJMC4kvDctm92g?si=a6b16fb33aba44fa From Ashes to Assets On July 5, 2023, a massive fire at Megachem’s facilities served...
SGX-LISTED COMPANIES

ABR Holdings Makes A $427 Million Pivot In FY2025

https://open.spotify.com/episode/0ETGmmjTvjwcdR3IXscy7U?si=ff4f99c684184cc3 From Sundaes to Skyscrapers: Can ABR Group’s $427 Million Pivot Hedge Against a Squeezed...
SGX-LISTED COMPANIES

Singapore Land’s Massive FY2025 Sydney Move

https://open.spotify.com/episode/6f08AonwL5YmfCa6dad1mS?si=89f0a8a1e4194aea To the casual observer, Singapore Land Group Limited’s (SingLand) FY2025 results present a riddle....
SGX-LISTED COMPANIES

Sing Holdings Bags Over 1000% Profit In FY2025

https://open.spotify.com/episode/4kMuadqKhQ9EoAGWizU6v8?si=d1d98a0862ae44e5 From Milestone to Masterplan: 5 Impactful Lessons from Sing Holdings’ Record-Breaking Year The $142 Million...
SGX-LISTED COMPANIES

Is Multi-Chem The Next Big Tech Play? – FY2025

https://open.spotify.com/episode/6bsUdttNHw2Cmt7zvBx2mx?si=5e9cdf1ae09c4cc0 5 Surprising Takeaways from Multi-Chem’s 2025 Shift Introduction: To the casual observer, the name "Multi-Chem Limited"...
SGX-LISTED COMPANIES

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Introduction: A Half-Century of Evolution As Raffles Medical Group (RMG) marks its 50th anniversary, it...
SGX-LISTED COMPANIES

Why Overseas Education Profits Plummeted 96% In FY2025

https://open.spotify.com/episode/45q3XuItaUJ8FnPWpg7EN2?si=22ec8dc230cc4725 The S$206,000 Reality: Overseas Education Limited and the High Cost of Staying Elite In the...
SGX-LISTED COMPANIES

Is The Global Timber Shortage About To Change Everything For Sitra Holdings? – FY2025

Revenue is Up, but the Bottom Line is Down: 5 Surprising Realities from Sitra...
SGX-LISTED COMPANIES

Kingsmen Creatives FY2025 Profit Rises As Revenue Shrinks

The Art of Doing More with Less: 5 Lessons from Kingsmen’s Tactical Pivot Global brands...
SGX-LISTED COMPANIES

How Singapura Finance Finessed A 50% Profit Surge In FY2025

Introduction: The Ministry of Trade and Industry recently confirmed that the Singapore economy grew by...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...